Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation

Molecular Cancer Therapeutics
Jing-Hung WangA C Matin

Abstract

This paper deals with specific targeting of the prodrug/enzyme regimen, CNOB/HChrR6, to treat a serious disease, namely HER2+ human breast cancer with minimal off-target toxicity. HChrR6 is an improved bacterial enzyme that converts CNOB into the cytotoxic drug MCHB. Extracellular vesicles (EV) were used for mRNA-based HchrR6 gene delivery: EVs may cause minimal immune rejection, and mRNA may be superior to DNA for gene delivery. To confine HChrR6 generation and CNOB activation to the cancer, the EVHB chimeric protein was constructed. It contains high-affinity anti-HER2 scFv antibody (ML39) and is capable of latching on to EV surface. Cells transfected with EVHB-encoding plasmid generated EVs displaying this protein ("directed EVs"). Transfection of a separate batch of cells with the new plasmid, XPort/HChrR6, generated EVs containing HChrR6 mRNA; incubation with pure EVHB enabled these to target the HER2 receptor, generating "EXO-DEPT" EVs. EXO-DEPT treatment specifically enabled HER2-overexpressing BT474 cells to convert CNOB into MCHB in actinomycin D-independent manner, showing successful and specific delivery of HChrR6 mRNA. EXO-DEPTs-but not undirected EVs-plus CNOB caused near-complete growth arrest of orthotopic BT474 x...Continue Reading

References

Aug 11, 1995·The Journal of Biological Chemistry·J ZabnerM J Welsh
Jul 20, 1999·Clinical & Experimental Metastasis·M LelekakisR L Anderson
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Jan 14, 2003·Trends in Molecular Medicine·Andrew R ReynoldsKairbaan Hodivala-Dilke
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yingjuan Lu, Philip S Low
Apr 20, 2004·Cancer Cell·Matthew C FranklinMark X Sliwkowski
Aug 10, 2005·Blood Cells, Molecules & Diseases·Alain DelcayreJean-Bernard Le Pecq
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Jan 25, 2006·Molecular Cancer Therapeutics·Yoram BarakA Matin
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Oct 24, 2007·Cancer Letters·Markus Jensen, Frank Berthold
Jun 20, 2008·The Journal of Gene Medicine·Kenya OkumuraToshiro Tagawa
Feb 5, 2009·Molecular Cancer Therapeutics·Steve H ThorneA Matin
Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Prashant PatelNicholas D James
Dec 17, 2009·Human Gene Therapy·Ellen SchenkRalph Willemsen
Jan 19, 2010·International Journal of Pharmaceutics·S ZouJ G Hecker
Mar 23, 2011·Nature Biotechnology·Lydia Alvarez-ErvitiMatthew J A Wood
Apr 12, 2011·Nature Biotechnology·Jasper G van den BoornGunther Hartmann
Oct 14, 2011·The New England Journal of Medicine·Dennis SlamonUNKNOWN Breast Cancer International Research Group
May 5, 2012·Frontiers in Physiology·Carsten FrühbeisEva-Maria Krämer-Albers
May 29, 2012·Cancer Letters·Sónia DuarteValérie Pierrefite-Carle
Jul 4, 2012·Advanced Drug Delivery Reviews·Jasper G van den BoornGunther Hartmann
Aug 28, 2012·Advanced Drug Delivery Reviews·Samir El AndaloussiMatthew J A Wood
Oct 4, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shin-ichiro OhnoMasahiko Kuroda
Jan 25, 2013·Molecular Therapy. Nucleic Acids·Mehmet Fatih BolukbasiOkay Saydam
Sep 4, 2013·Molecular Neurobiology·Anuradha KalaniNeetu Tyagi
Oct 17, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie L KasperzykLorelei A Mucci
Nov 20, 2013·Journal of Pharmacology & Pharmacotherapeutics·Jaykaran Charan, N D Kantharia
Apr 2, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Fatemeh Momen-HeraviGyongyi Szabo
May 20, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mohd Javed AkhtarSudhir Kumar
Oct 8, 2014·Annual Review of Cell and Developmental Biology·Marina ColomboClotilde Théry
Nov 27, 2014·Frontiers in Cellular Neuroscience·Hongqi XinMichael Chopp
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Masamitsu KanadaChristopher H Contag

❮ Previous
Next ❯

Citations

Aug 14, 2020·Journal of Drug Targeting·Mohd MugheesSaima Wajid
Jul 3, 2020·International Journal of Molecular Sciences·Katarzyna Nazimek, Krzysztof Bryniarski
Sep 1, 2018·Journal of Nanobiotechnology·Travis J AntesEduardo Marbán
Oct 31, 2019·Pharmaceutics·Federico VillaRoberta Tasso
Apr 1, 2020·Frontiers in Cell and Developmental Biology·Austin GowenSowmya V Yelamanchili
Mar 16, 2019·Experimental & Molecular Medicine·Daniel E MurphyPieter Vader
Dec 15, 2019·Cancers·Francesca SusaValentina Cauda
Nov 19, 2020·Molecular Oncology·Antonia Schubert, Michael Boutros
Aug 28, 2019·Molecular Cancer Therapeutics·Masamitsu KanadaChristopher H Contag
Jun 25, 2019·Cancer Letters·Hong-Xia Wang, Olivier Gires
Jan 8, 2021·Endocrinology·Fernanda G KugeratskiRaghu Kalluri
Feb 24, 2020·Biotechnology Advances·Yuhua WengYuanyu Huang
Aug 20, 2019·Seminars in Cancer Biology·Vadim V TarasovGjumrakch Aliev
Feb 21, 2021·Seminars in Cancer Biology·Migara Kavishka JayasingheMinh T N Le
Feb 12, 2021·Endocrinology·Fernanda G KugeratskiRaghu Kalluri
Mar 12, 2021·BMC Biotechnology·Cynthia AslanReza Jafari
Mar 18, 2021·Nanomedicine·Mahlegha GhavamiMehdi Forouzandeh Moghadam
May 25, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elise R RobinsonSanjiv S Gambhir
May 21, 2021·Advanced Drug Delivery Reviews·Pol Escudé Martinez de CastillaJiong-Wei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.